Related stories
Eton Pharmaceuticals Raises Full-Year Outlook After Third-Quarter Revenue More Than Doubles
Eton Pharmaceuticals raised its outlook for the year after third-quarter revenue more than doubled. The stock rose 12% to $52.59 on Friday.
M impact | EQUITY | Nov 06, 2026, 03:18 PM UTC
Firefly Inks $1.3 Billion Deal to Supply AST SpaceMobile Rocket Engines
Firefly Aerospace will supply core engines for AST SpaceMobile’s new rocket under development, in a deal valued at $1.3 billion.
M impact | EQUITY | Nov 06, 2026, 03:15 PM UTC
York Water Q3 Revenue Rises 20% on Rate Hike, Customer Growth
M impact | EQUITY | Nov 06, 2026, 03:13 PM UTC
Brazil’s Ibovespa Rises 1% Near 168,000 as Wall Street Rebounds
The Ibovespa rose 1% Friday, with gains across major banks and utilities. Sabesp advanced nearly 5% after reporting a 9% year-over-year increase in Q3 revenue.
M impact | EQUITY | Nov 06, 2026, 03:10 PM UTC
US session market picture: S&P 500 +1%, Nasdaq 100 +2.42%; EUR/USD -0.58%, WTI +0.32%, WBD leads volume
US session market picture. US index futures: S and P futures is up 1 percent, Nasdaq futures is up 2.42 percent, Dow futures is down 0.23 percent and Russell futures is up 0.57 per
M impact | EQUITY | Nov 06, 2026, 03:02 PM UTC
Mettler-Toledo Reports Third-Quarter Revenue of $1.09B, EPS of $12.29
Third-quarter sales and earnings increased year over year. Sales rose 6% in U.S. dollars; improved gross margin reflected favorable price realization, lower tariff costs and higher
M impact | EQUITY | Nov 06, 2026, 03:01 PM UTC